US Futures gaining ground, watch MRK, REGN, HPE, AZO

The S&P 500 futures remain on the upside after they were closed for the Memorial Day.


The S&P 500 futures remain on the upside after they were closed for Memorial Day. However, major stock index (Dow, S&P 500, Nasdaq 100) futures were still up over 1%.

Later today, the Conference Board will publish May Consumer Confidence Index (87.0 expected). The Federal Reserve Bank of Chicago will post March National Activity Index (-3 expected). The Commerce Department will release April new home sales (480,000 units expected). SP/Case-Shiller will report 20-City Composite Home Price Index for March (+0.3% on month expected). The Federal Housing Finance Agency will release its House Price Index for March (+0.5% on month expected). The Federal Reserve Bank of Dallas will post its Manufacturing Activity Index for May (-62.0 expected).

European indices opened higher thanks to a bullish gap and remain well directed. Germany's GfK Consumer Confidence Index for June was released at -18.9 (vs -18.2 expected).

Asian indices closed well in the green. Government data showed that New Zealand recorded a trade surplus of 1.27 billion New Zealand dollars in April (1.24 billion New Zealand dollars surplus expected), where exports totaled 5.26 billion New Zealand dollars (5.30 billion New Zealand dollars expected).

WTI Crude Oil Futures remain on the upside. IEA's Executive Director Fatih Birol said: "In the absence of strong government policies, a sustained economic recovery and low oil prices are likely to take global oil demand back to where it was, and beyond."

Gold fell 7.74$ (-0.45%) to 1724.21, losing some ground on rallying equities. 

The US Dollar is weakening against its major peers on reopening economies. The EUR/USD gained 57pips to 1.0955 while GBP/USD jumped 123pips to 1.2314. The Bank of England said that most recent economic data were better than anticipated.

US Equity Snapshot

Merck (MRK), the pharma giant, unveiled "three significant scientific initiatives to combat COVID-19." The company announced the acquisition of "Themis Bioscience, a company focused on vaccines and immune-modulation therapies for infectious diseases, including COVID-19." IAVI, a nonprofit scientific research organization, and Merck will "collaborate to develop vaccine against COVID-19". Finally, Merck and Ridgeback Bio will collaborate to advance development of an oral antiviral candidate for COVID-19, EIDD-2801."

Regeneron Pharmaceuticals (REGN), a biotechnology company, is expected to lose ground as Sanofi plans to sell most of its 20.6% stake in the company. Regeneron reported has agreed to repurchase 5 billion dollars of its shares from French pharmaceutical group, where Sanofi also intends to sell 12.8 million shares in the company through public offering.

Hewlett Packard Enterprise, (HPE), a supplier of information technology products and services, was upgraded to "neutral" from "underweight" at JPMorgan.

AutoZone (AZO), the leading retailer and distributor of automotive replacement parts and accessories in the U.S., reported third quarter EPS of 14.39 dollars, more than forecast, down from 15.99 dollars a year ago, on sales flat at 2.78 billion dollars, above estimates.

Source : TradingVIEW, GainCapital

Build your confidence risk free

More from Equities

Join our live webinars for the latest analysis and trading ideas. Register now

StoneX Financial Ltd (trading as “City Index”) is an execution-only service provider. This material, whether or not it states any opinions, is for general information purposes only and it does not take into account your personal circumstances or objectives. This material has been prepared using the thoughts and opinions of the author and these may change. However, City Index does not plan to provide further updates to any material once published and it is not under any obligation to keep this material up to date. This material is short term in nature and may only relate to facts and circumstances existing at a specific time or day. Nothing in this material is (or should be considered to be) financial, investment, legal, tax or other advice and no reliance should be placed on it.

No opinion given in this material constitutes a recommendation by City Index or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although City Index is not specifically prevented from dealing before providing this material, City Index does not seek to take advantage of the material prior to its dissemination. This material is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

For further details see our full non-independent research disclaimer and quarterly summary.